Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: a nationwide target trial emulation study Byungyoon Yun; Juyeon Oh; Heejoo Park; Jian Lee; Beom Kyung Kim; Jin-Ha Yoon;

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;

Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study Golasa Samadi Kochaksaraei; Fengjuan Yang; Cynthia H. Seow; Herman W Barkema; Carla S Coffin; Abdel-Aziz Shaheen;